Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline

Posted on by sHq_LoGiNz

CAMBRIDGE, England–(BUSINESS WIRE)–Alchemab Therapeutics appoints Dr Ben Porter-Brown as Chief Medical Officer to accelerate clinical development of highly novel antibody therapeutics.

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.